Upregulation of the MMP-2 in the fibroblasts neighboring the tumor was observed in about 50% of the NSCLC patients, enabling malignant transformation by ECM degradation and the creation of a suitable microenvironment for vessel growth [43]. Here, MMP2 is linked to neoplasm.